Roche Holding AG , Genentech, Inc. and their affiliated companies were the busiest deal makers in the biopharmaceutical sector for the second consecutive year in 2021, with 23 deals across all cate
Device Transactions Device firms raised a total of $1.6 billion in 2014’s second quarter, a significant increase – 123% – over Q1’s $714 million. In Q2 there were strong representations from late-stag
IN VITRO DIAGNOSTICS Epic Sciences Inc. Series C brings $30mm to Epic Sciences Epic Sciences Inc. (molecular diagnostics for cancer) closed a $30mm Series C round. New investors RusnanoMedInve